References

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 148 CE courses, most popular
$95Add to cart
Pick Your Courses
Up to 8 CE hours
$50Add to cart
Individual course$20Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Detection and Management of Preeclampsia: Current Laboratory Testing and Emerging Biomarkers. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Detection and Management of Preeclampsia: Current Laboratory Testing and Emerging Biomarkers (online CE course)
References

ACOG Statement on USPSTF Recommendations for Screening for Preeclampsia. Available at https://www.acog.org/news/news-releases/2017/04/acog-statement-on-uspstf-final-recommendations-on-screening-for-preeclampsia. Accessed June 25, 2021.
ACOG 2019, Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia, Obstetrics & Gynecology: January 2019 - Volume 133 - Issue 1 - p e1-e25. Accessed June 25, 2021.
Barbieri, R L, Start offering aspirin to pregnant women at high risk of preeclampsis, OBG Manag, 2016, May: 28, 8-12, available at https://www.mdedge.com/obgmanagement/article/108536/obstetrics/start-offering-aspirin-pregnant-women-high-risk-preeclampsia . Accessed June 25, 2021.
Carty DM, Delles C, Dominiczak AF. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med. 2008July;18(5-24):186-194. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577131/. Accessed June 25, 2021.
Cause of Preeclampsia. Preeclampsia Foundation website. Available at: https://www.preeclampsia.org/cause-of-preeclampsia. Accessed June 25, 2021.
Diagnosis and Treatment of Preeclampsia, Mayo Clinic, available at https://www.mayoclinic.org/diseases-conditions/preeclampsia/diagnosis-treatment/drc-20355751. Accessed June 25, 2021.
Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009 Jun;33(3):130-137.
Giguere Y, Charland M, Bujold E, et al. Combining biochemical and ultrasonographic markers to predict preeclampsia. Clin Chem. 2010Mar; 56:3:361-375.
Grill S, Rusterholz C, Zanetti-Dällenbach R. Potential markers of preeclampsia -- a review. Reprod Biol Endocrinol. 2009 Jul 14:7:70.
Herraiz, I et al, Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1/PIGF ratio in singleton pregnancies, Fetal Diag Ther, 2018, 43:81-89, available at https://www.karger.com/Article/FullText/477903. Accessed June 25, 2021.
Human VEGF Quantikine® ELISA Kit, R&D Systems, [Product Insert]. Available at: http://www.rndsystems.com/Products/DVE00. Accessed June 25, 2021.
Huppertz B. Meiri H, Gizurarson S, et al. Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia. Hum Reprod Update. 2013;19(4):391-405.
Lambert-Mes serlian GM, Palomaki GE, Neveux LM, et al. Early onset preeclampsia and second trimester serum markers. Prenat Diagn. 2009;29(12):1109-1117. Available at:
Levine RJ, Lam C, Qian C. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005.
Lim, KH, Ramus RM. Preeclampsia. Medscape website. Available at: http://emedicine.medscape.com/article/1476919-overview. Accessed June 25, 2021.
Masoura S, Kalogiannidis IA, Gitas G, et al. Biomarkers in pre-eclampsia: a novel approach to early detection of the disease. J Obstet Gynaecol . 2012 Oct;32(7):609-616.
Preeclampsia: Labtestsonline, AACC, available at https://labtestsonline.org/conditions/pre-eclampsia. Accessed June 25, 2021.
Preeclampsia and Eclampsia. WebMD website. Available at: http://www.webmd.com/baby/guide/preeclampsia-eclampsia. Accessed June 25, 2021.
Preeclampsia risk factors. Mayo Clinic Health Information. Available at http://www.mayoclinic.com/health/preeclampsia/DS00583/DSECTION=risk-factors. Accessed June 25, 2021.
Preeclampsia Screening Recommendations Update, Cardiology Advisor, available at https://www.thecardiologyadvisor.com/hypertension/preeclampsia-screening-recommendations-updated/article/661203/. Accessed June 25, 2021.
Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction, J Mayrink et al, The Scientific World Journal, Volume 2018, Article ID 6268276, available at
https://www.hindawi.com/journals/tswj/2018/6268276/ Accessed June 25, 2021.
US Preventive Services Task Force; Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for preeclampsia: US Preventive Services Task Force Recommendation Statement.JAMA. 2017;317(16):1661-1667. Accessed June 25, 2021.
Venkatesha S, Toporsian M, Lam C, Hanai J, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642–9.
Verlohren S, Herraiz I, Lapaire O, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012 Jan;206(1):58 e1-8.
Zhou, Q, Liu H, Qiao F, et al. VEGF deficit is involved in endothelium dysfunction in preeclampsia. J Huazhong Univ Sci Technolog Med Sci. 2010 Jun;30(3):370-374.